New Zealand has announced a ban on new prescriptions of puberty blockers for young transgender individuals, effective December 19. This decision follows a review by the health ministry, which found a lack of “high-quality evidence that demonstrates the benefits or risks” associated with the use of these medications.
The ban reflects ongoing discussions and concerns regarding the treatment options available to transgender youth. As previously reported, similar situations have arisen in other countries, prompting debates about the appropriate medical care for this population.
For more information on related coverage, visit recent developments in political news.

Image for New Zealand bans new prescriptions of puberty blockers for youth






